Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |
mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |